In January, the Child Family Institute for Innovation and Entrepreneurship received international recognition of its efforts to commercialize science and engineering breakthroughs, when China-based life sciences startup Anpac Bio-Medical Science Co. pledged $50,000 to underwrite student fellowships and to support the annual UC Davis Biomedical + Engineering Entrepreneurship Academy’s keynote event.
Executive Director | UC Davis Child Family Institute for Innovation and Entrepreneurship
“When I met the institute’s leadership team and learned about their goals and programs, I was very impressed,” said Anpac Bio CEO Chris Yu. “I liked their mission of fostering disruptive scientific innovation, while simultaneously preparing students to integrate their solutions in the global marketplace.
“Students who possess the unique skillset of scientific excellence, creativity, motivation and dedication may eventually become outstanding employees for our company,” he added.
Specifically, Anpac Bio’s $10,000 per year/five-year commitment will host the BMEA’s launch event in July and underwrite student fellowships at the annual UC Entrepreneurship Academy (UCEA) in the fall.
The academies provide a deep immersion in business planning for aspiring and early-stage entrepreneurs, and are one of the University of California’s premier programs for commercializing science and engineering innovations.
The BMEA is co-sponsored by the UC Davis Biomedical Engineering Department, School of Medicine, School of Veterinary Medicine, Office of Research and the Child Family Institute for Innovation and Entrepreneurship.
CEO | Anpac Bio-Medical Science Co.
“We are very excited to enter into this new partnership,” said institute executive director Cleveland Justis. “Anpac Bio’s sponsorship will underwrite a terrific launch event for our Biomedical + Engineering Entrepreneurship Academy and attract world-renowned speakers to inspire our students. We are honored that Dr. Yu has agreed to give this year’s keynote address.
“The UCEA fellowships will allow us the funding and flexibility to recruit life science’s brightest minds and most talented academics who display promise as entrepreneurs or ‘corporate intrepreneurs,’ to attend our academies.”
Just weeks after making the UC Davis commitment, Anpac Bio announced that it will locate its U.S. headquarters in Sacramento, drawn by the region’s relatively lower cost of doing business and stable workforce. Mayor Kevin Johnson shared the news at his State of the City address on January 28.
“We can’t just be a city for basketball fans, government officials and tech giants,” Johnson said. “We also have to be a city for families, college students and young professionals. We have to be a city for the homeless, the less fortunate and the underemployed. We have to be a city that works for everyone.”
Chris Yu and Herbert Yu founded Anpac in 2008 to answer the critical question: “What if we could detect cancer before tumors start?” Today, the company’s multinational team of medical, biomedical and nanotechnology scientists, and engineering experts employ a unique, cross-disciplinary approach to achieve superior early cancer screening and detection technology.
Anpac Bio will open a 4,000-square-feet office in East Sacramento and plans to later build a 50,000-square-foot research center. The company anticipates hiring 250 workers within two years, and creating up to 1,000 new jobs over time, and hopes to work closely with Dignity Health, UC Davis Medical Center, Sutter Medical and Kaiser Permanente to develop its diagnostic systems and conduct the clinical trials necessary for Food and Drug Administration approval.
Image courtesy courtesy of Anpac Bio, Sagent Marketing and Fuel Creative.
Leave a Reply